Hands-On Learning: Local Group Tours McMurray Lab for Breast Cancer Research
Ten years ago, breast cancer was viewed and treated as a single disease. Today, information from the genes within a tumor are used to define which women benefit from chemotherapy, and whether or not additional targeted treatment may improve outcomes. This strategy minimizes side effects and improves quality of life for patients.
Members of the Breast Cancer Research Initiative, a Wilmot Cancer Center donor-driven group, received a tour of the McMurray Lab in mid-June to learn about these strategies and how cutting-edge research is helping to evolve breast cancer therapies.
Hosted by Hucky Land, Ph.D., director of research and co-director of the Wilmot Cancer Center; Kristin Skinner, M.D., chief of Surgical Oncology and director of the Multidisciplinary Breast Cancer; and Helene McMurray, Ph.D., the group explored the various areas of the laboratory where research takes place, met the team of researchers, and learned more about the research that is helping the Cancer Center implement precision medicine to breast cancer patients in the clinic.
The Breast Cancer Research Initiative meets two to three times a year to discuss the newest research discoveries – inviting Wilmot physicians and scientists to discuss their experiences in dealing with breast cancer. The group has raised more than $100,000, providing seed grants to support ongoing breast cancer research.
Click here to download the print version of Dialogue